Have a personal or library account? Click to login
Genotype Variability and Haplotype Profile of Abcb1 (Mdr1) Gene Polymorphisms in Macedonian Population Cover

Genotype Variability and Haplotype Profile of Abcb1 (Mdr1) Gene Polymorphisms in Macedonian Population

PRILOZI
Volume 35 (2014): Issue 3 (December 2014)
By:
Open Access
|Mar 2015

References

  1. 1. Franke R.M. Gardner E.R and A. Sparreboom, Pharmacogenetics of Drug Transporters Current Pharmaceutical Desig. 2010; 16: 220-230.
    Search in Google Scholar
  2. 2. Zhu Hao-Jie, Wang Jun-Sheng, Markowitz SJ, Donovan LJ, Gibson BB and DeVane CL. Risperidone and Paliperidone Inhibit P-Glycoprotein Activity In Vitro Neuropsychopharmacology. 2007; 32, 757-764.
    Search in Google Scholar
  3. 3. Bruhn O, Cascorbi I. Polymorphisms of drug transporters ABCB1, ABCG2, ABCC2 and ABCC3 and their impact on drug bioavailability and clinical relevance. Expert Opin Drug Metab Toxicol. 2014; 10: 1337-54.10.1517/17425255.2014.95263025162314
    Search in Google Scholar
  4. 4. Chandler B, Detsika M, Khoo SH, et al. Factors impacting the expression of membrane-bound proteins in lymphocytes from HIV-positive subjects. J Antimicrob Chemother. 2007; 60: 685-9.10.1093/jac/dkm23017606483
    Search in Google Scholar
  5. 5. Svirnovski AI, Shman TV, Serhiyenka TF, et al. ABCB1 and ABCG2 proteins, their functional activity and gene expression in concert with drug sensitivity of leukemia cells. Hematology (Am Soc Hematol Educ Program). 2009; 14: 204-12.10.1179/102453309X42621819635183
    Search in Google Scholar
  6. 6. Marzolini C, Paus E, Buclin T and Kim R B. Polymorphisms in human MDR1 (P-glycoprotein): recent advances and clinical relevance. Clin Pharmacol Ther. 2004; 75 (1): 13-33.10.1016/j.clpt.2003.09.01214749689
    Search in Google Scholar
  7. 7. Gottesman MM, Hrycyna CA, Schoenlein PV, Germann UA and Pastan I. Genetic analysis of the multidrug transporter. Annu Rev Genet 29; 1995; 607-649.10.1146/annurev.ge.29.120195.0031358825488
    Search in Google Scholar
  8. 8. Sugawara I, Kataoka K, Morishita Y, et al. Tissue distribution of P-glycoprotein encoded by a multidrugresistant gene as revealed by a monoclonal antibody. MRK 16. Cancer Res. 48: 1926-1929.
    Search in Google Scholar
  9. 9. Hoffmeyer S, Burk O, von Richter O, Arnold HP, Brockmö ller J, Johne A, et al. Functional polymorphism of the human multidrug-resistance gene: multiple sequence variations and correlations of one allele with P-glycoprotein expression and activity in vivo. Proc Natl Acad Sci USA. 2000; 97: 3473-3478.10.1073/pnas.97.7.34731626410716719
    Search in Google Scholar
  10. 10. Nakamura T, Sakaeda T, Horinouchi M, Tamura T, Aoyama N, Schirakawa T, et al. Effect of the mutation (C3435T) et exon 26 of the MDR1 gene on expression level of MDR1 messenger ribonucleic acid in duodenal enterocytes of healthy Japanese subjects. Clin Pharmacol Ther. 2002; 71: 297-303.10.1067/mcp.2002.12205511956513
    Search in Google Scholar
  11. 11. Nikisch G, Eap CB and Baumann P. Citalopram enantiomers in plasma and cerebrospinal fluid of ABCB1 genotyped depressive patients and clinical response: a pilot study. Pharmacol Res. 2008; 58: 344-347.10.1016/j.phrs.2008.09.01018940259
    Search in Google Scholar
  12. 12. Uhr M, Grauer MT, Yassouridis A and Ebinger M. Blood- brain barrier penetration and pharmacokinetics of amitriptyline and its metabolites in p-glycoprotein (abcb1ab) knock-out mice and controls. J Psychiatr Res. 2007; 41: 179-188.10.1016/j.jpsychires.2005.10.00516387324
    Search in Google Scholar
  13. 13. Gex-Fabry M, Eap CB, Oneda B, Gervasoni N, Aubry JM, Bondolfi G, et al. CYP2D6 and ABCB1 genetic variability: Influence on paroxetine plasma level and therapeutic response. Ther Drug Monit 2008; 30: 474-482.10.1097/FTD.0b013e31817d6f5d18641553
    Search in Google Scholar
  14. 14. Loscher W and Potschka H. Role of multidrug transporters in pharmacoresistance to antiepileptic drugs. J Pharmacol Exp Ther. 2002; 301: 7-14.10.1124/jpet.301.1.7
    Search in Google Scholar
  15. 15. Wolf SJ, Bachtiar M, Wang J, Sim TS, Chong SS and Lee CGL, An update on ABCB1 pharmacogenetics: insights from a 3D model into the location and evolutionary conservation of residues corresponding to SNPs associated with drug pharmacokinetics. The Pharmacogenomics Journal. 2011; 11: 315-325.10.1038/tpj.2011.16
    Search in Google Scholar
  16. 16. Tang K, Ngoi SM, Gwee PC, Chua JM, Lee EJ, Chong SS et al. Distinct haplotype profiles and strong linkage disequilibrium at the MDR1 multidrug transporter gene locus in three ethnic Asian populations. Pharmacogenetics. 2002; 12: 437-450.10.1097/00008571-200208000-00004
    Search in Google Scholar
  17. 17. Kim DH, Lee NY, Sung WJ, Baek JH, Kim JG, Sohn SK, et al. Multidrug resistance as a potential prognostic indicator in acute myeloid leukemia with normal karyotypes. Acta Haematol. 2005; 114(2): 78-83.10.1159/000086579
    Search in Google Scholar
  18. 18. Dulucq S, Bouchet S, Turcq B, Lippert E, Etienne G, Reiffers J, et al. Multidrug resistance gene (MDR1) polymorphisms are associated with major molecular responses to standard-dose imatinib in chronic myeloid leukemia. Blood. 2008; 112: 2024-2027.10.1182/blood-2008-03-147744
    Search in Google Scholar
  19. 19. Ekhart C, Rodenhuis S, Smits PHM, Beijnen JH, and Huitem, ADR. An overview of the relations between polymorphisms in drug metabolising enzymes and drug transporters and survival after cancer drug treatment. Cancer Treat Rev. 2009; 35: 18-31.10.1016/j.ctrv.2008.07.003
    Search in Google Scholar
  20. 20. Vivona D, Bueno CT, Lima LT, Hirata RDC, Hirata MH, Luchessi AD, et al. ABCB1 haplohaplotype is associated with major molecular response in chronic myeloid leukemia patients treated with standard-dose of imatinib. Blood Cells Mol Dis. 2012; 48: 132-136.10.1016/j.bcmd.2011.11.001
    Search in Google Scholar
  21. 21. Rubis B, Holysz H, Barczak W, Gryczka R, Lacinski M, et al. Study of ABCB1 polymorphism frequency in breast cancer patients from Poland. Pharmacol Rep. 2012; 64: 1560-1566. 2012.10.1016/S1734-1140(12)70954-4
    Search in Google Scholar
  22. 22. Johne A, Kopke K, Gerloff T, Mai I, Rietbrock S, Meisel C, et al. Modulation of steady-state kinetics of digoxin by haplotypes of the P- glycoprotein MDR1 gene. Clin Pharmacol Ther. 2002; 72(5): 584-94.10.1067/mcp.2002.12919612426522
    Search in Google Scholar
  23. 23. Chowbay B, Cumaraswamy S, Cheung YB, Zhou Q, Lee EJ. Genetic polymorphisms in MDR1 and CYP3A4 genes in Asians and the influence of MDR1 haplotypes on cyclosporin disposition in heart transplant recipients. Pharmacogenetics. 2003; 13(2): 89-95.10.1097/00008571-200302000-0000512563178
    Search in Google Scholar
  24. 24. Yi SY, Hong KS, Lim HS, Chung JY, Oh DS, Kim JR, et al. A variant 2677A allele of the MDR1 gene affects fexofenadine disposition. Clin Pharmacol Ther. 2004; 76(5): 418-27.10.1016/j.clpt.2004.08.00215536457
    Search in Google Scholar
  25. 25. Tsai CJ, Sauna ZE, Kimchi-Sarfaty C, Ambudkar SV, Gottesman MM, Nussinov R. Synonymous mutations and ribosome stalling can lead to altered folding pathways and distinct minima. J Mol Biol. 2008; 383: 281-291.10.1016/j.jmb.2008.08.012262838918722384
    Search in Google Scholar
  26. 26. Crettol S, Deglon JJ, Besson J, Croquette-Krokar M, Hammig R, Gothuey I, et al. ABCB1 and cytochrome P450 genotypes and phenotypes: influence on methadone plasma levels and response to treatment. Clin Pharmacol Ther. 2006; 80: 668-681.10.1016/j.clpt.2006.09.01217178267
    Search in Google Scholar
  27. 27. Shi YY, He L. SHEsis, a powerful software platform for analyses of linkage disequilibrium, haplotype construction, and genetic association at polymorphism loci. Cell Res. 2005; 15(2): 97-8.10.1038/sj.cr.729027215740637
    Search in Google Scholar
  28. 28. Li Z, Zhang Z, He Z, Tang W, Li T, Zeng Z, et al. A partition-ligation-combination-subdivision EM algorithm for haplotype inference with multiallelic markers: update of the SHEsis (http://analysis.bio-x-cn). Cell Res. 2009; 19(4): 519-23.10.1038/cr.2009.3319290020
    Search in Google Scholar
  29. 29. Sai K, Kaniwa N, Itoda M, Saito Y, Hasegawa R, Komamura, et al. Haplotype analysis of ABCB1- MDR1 blocks in a Japanese population reveals genotype- dependent renal clearance of irinotecan. Pharmacogenetics. 2003; 13: 741-757.10.1097/00008571-200312000-0000514646693
    Search in Google Scholar
  30. 30. Wasilewska A, Zalewski G, Chyczewski L, and Zoch-Zwierz W. MDR1 gene polymorphisms and clinical course of steroid-responsive nephrotic syndrome in children. Pediatr Nephrol. 2007; 22: 44-51.10.1007/s00467-006-0275-317043887
    Search in Google Scholar
  31. 31. Xu P, Jiang ZP, Zhang BK, Tu JY, and Li HD. Impact of MDR1 haplotypes derived from C1236T, G2677T=A and C3435T on the pharmacokinetics of single-dose oral digoxin in healthy Chinese volunteers. Pharmacology. 2008; 82: 221-227.10.1159/00015648818810246
    Search in Google Scholar
  32. 32. Pechandova D, Buzkova K H, Slanar O, and Perlík F. Polymorphisms of the MDR1 gene in the Czech population. Folia Biol (Praha). 2006; 52: 184-189.
    Search in Google Scholar
  33. 33. Komoto C, Nakamura T, Sakaeda T, Kroetz DL, Yamada T, et al. MDR1 haplotype frequencies in Japanese and Caucasian, and in Japanese patients with colorectal cancer and esophageal cancer. Drug Metab Pharmacokinet. 2006; 21: 126-132.10.2133/dmpk.21.12616702732
    Search in Google Scholar
  34. 34. Lee SS, Kim SY, Kim WY, Thi-Le H, Yoon YR, Yea SS and Shin JG. MDR1 genetic polymorphisms and comparison of MDR1 haplotype profiles in Korean and Vietnamese populations. Ther Drug Monit. 2005; 27: 531-535.10.1097/01.ftd.0000164293.75854.1116044113
    Search in Google Scholar
  35. 35. Halim Salem A, Ali M, Ibrahim A and Ibrahim M. Genotype and Allele Frequencies of MDR-1 Gene Polymorphism in Jordanian and Sudanese Populations American Journal of Medicine Studies. 2014; 1: 19-23.
    Search in Google Scholar
  36. 36. Gonzalez TP, Mucenic T, Brenol JC, Xavier RM, Schiengold M, Chies JA. ABCB1 C1236T, G2677T/A and C3435T polymorphisms in systemic lupus erythematosus patients. Braz J Med Biol Res. 2008; 41(9): 769-72.10.1590/S0100-879X200800090000518820766
    Search in Google Scholar
  37. 37. Sipeky C, Csongei V, Jaromi L, Safrany E, Maasz A, Takacs I, et al. Genetic variability and haplotype profile of MDR1 (ABCB1) in Roma and Hungarian population samples with a review of the literature. Drug Metab Pharmacokinet. 2011; 26(2): 206-15.10.2133/dmpk.DMPK-10-SC-06821178299
    Search in Google Scholar
  38. 38. Marie-Genica Consortium on Genetic Susceptibility for Menopausal Hormone Therapy Related Breast Cancer Risk. “Polymorphisms in the BRCA1 and ABCB1 genes modulate menopausal hormone therapy associated breast cancer risk in postmenopausal women. Breast Cancer Res Treat. 2010; 120 (3): 727-736.10.1007/s10549-009-0489-819672706
    Search in Google Scholar
  39. 39. Kafka A, Sauer G, Jaeger C, Grundmann R, Kreienberg R, Zeillinger R, Deissler H. Polymorphism C3435T of the MDR-1 gene predicts response to preoperative chemotherapy in locally advanced breast cancer. Int J Oncol. 2003; 22(5): 1117-21.10.3892/ijo.22.5.1117
    Search in Google Scholar
  40. 40. Simon T, Verstuyft C, Mary-Krause M, Quteineh L, Drouet E, Meneveau N, et al. Genetic determinants of esponse to clopidogrel and cardiovascular events. N Engl J Med. 2009; 360 (4): 363-375.10.1056/NEJMoa080822719106083
    Search in Google Scholar
  41. 41. Kim DH, Park JY, Sohn SK, Lee NY, Baek JH, Jeon SB, et al. Multidrugresistence-1 gene polymorphisms associated with treatment outcomes in de novo acute myeloid leukemia. Int J Cancer. 2006; 118(9): 2195- 201.10.1002/ijc.2166616331627
    Search in Google Scholar
  42. 42. Siddiqui A, Kerb R, Weale ME, Brinkmann U, Smith A, Goldstein DB, et al. Association of multidrug resistance in epilepsy with a polymorphism in the drugtransporter gene ABCB1. N Engl J Med. 2003; 348(15): 1442-8.10.1056/NEJMoa02198612686700
    Search in Google Scholar
  43. 43. E Shon JH, Yoon YR, Hong WS, Nguyen PM, Lee SS, Choi YG, et al. Effect of itraconazole on the pharmacokinetics and pharmacodynamics of fexofenadine in relation to the MDR1 genetic polymorphism. Clin Pharmacol Ther. 2005; 78: 191-201.10.1016/j.clpt.2005.04.01216084853
    Search in Google Scholar
  44. 44. F Cavaco I, Gil JP, Gil-Berglund E and Ribeiro V. CYP3A4 and MDR1 alleles in a Portuguese population. Clin Chem Lab Med. 2003; 41: 1345-1350.10.1515/CCLM.2003.20614580164
    Search in Google Scholar
  45. 45. Pan JH, Han JX, Wu JM, Huang HN, Yu QZ and Sheng LJ. MDR1 single nucleotide polymorphism G2677T=A and haplotype are correlated with response to docetaxelcisplatin chemotherapy in patients with non-small-cell lung cancer. Respiration. 2009; 78: 49-55.10.1159/00015845418812689
    Search in Google Scholar
  46. 46. Potocnik U, Glavac D and Dean M. Common germline MDR1/ABCB1 functional polymorphisms and haplotypes modify susceptibility to colorectal cancers with high microsatellite instability. Cancer Genet Cytogenet. 2008; 183: 28-34.10.1016/j.cancergencyto.2008.01.02318474294
    Search in Google Scholar
  47. 47. Wang D, Johnson AD, Papp AC, Kroetz DL and Sadee W. Multidrug resistance polypeptide 1 (MDR1, ABCB1) variant 3435C T affects mRNA stability. Pharmacogenet. Genomics. 2005; 15: 693-704.
    Search in Google Scholar
  48. 48. Kim RB, Leake BF, Choo EF. et al. Identification of functionally variant MDR1 alleles among European Americans and African Americans. Clin. Pharmacol. Ther. 2001; 70: 189-199.
    Search in Google Scholar
  49. 49. Urayama KY, Wiencke JK, Buffler PA, Chokkalingam AP, Metayer C and Wiemels JL. MDR1 gene variants, indoor insecticide exposure, and the risk of childhood acute lymphoblastic leukemia. Cancer Epidemiol Biomarkers Prev. 2007; 16: 1172-1177.10.1158/1055-9965.EPI-07-000717548681
    Search in Google Scholar
  50. 50. Kurzawski M, Pawlik A, Gornik W and Drozdzik M. Frequency of common MDR1 gene variants in a Polish population. Pharmacol. Rep. 2006; 58: 35-40.
    Search in Google Scholar
  51. 51. Kroetz DL, Pauli-Magnus C, Hodges LM. et al. Sequence diversity and haplotype structure in the human ABCB1 (MDR1, multidrug resistance transporter) gene. Pharmacogenetics. 2003; 13: 481-494.10.1097/00008571-200308000-0000612893986
    Search in Google Scholar
  52. 52. Gümüş-Akay G, Rüstemoğlu A, Karadağ A, Sunguroğlu A. Haplotype-based analysis of MDR1/ABCB1 gene polymorphisms in a Turkish population. DNA Cell Biol. 2010; 29: 83-90.10.1089/dna.2009.095320025534
    Search in Google Scholar
  53. 53. Bandur S, Petrasek J, Hribova P, Novotna E, Brabcova I and Viklicky O. Haplotypic structure of ABCB1/MDR1 gene modifies the risk of the acute allograft rejection in renal transplant recipients. Transplantation. 2008; 86(9): 1206-13.10.1097/TP.0b013e318187c4d119005401
    Search in Google Scholar
  54. 54. Wong M, Evans S, Rivory LP, Hoskins JM, Mann GJ, Farlow D, et al. Hepatic technetium Tc 99mlabeled sestamibi elimination rate and ABCB1 (MDR1) genotype as indicators of ABCB1 (P-glycoprotein) activity in patients with cancer. Clin Pharmacol Ther. 2005; 77(1): 33-42.10.1016/j.clpt.2004.09.00215637529
    Search in Google Scholar
  55. 55. Panczyk M, Balcerczak E, Piaskowski S, Jamroziak K, Pasz-Walczak G, Mirowski M. ABCB1 gene polymorphisms and haplotype analysis in colorectal cancer. Int J Colorectal Dis. 2009; 24(8): 895-905.10.1007/s00384-009-0724-019415305
    Search in Google Scholar
  56. 56. Sai K, Kaniwa N, Itoda M, Saito Y, Hasegawa R, Komamura K, et al. Haplotype analysis of ABCB1/MDR1 blocks in a Japanese population reveals genotype-dependent renal clearance of irinotecan. Pharmacogenetics. 2003; 13(12): 741-57.10.1097/00008571-200312000-0000514646693
    Search in Google Scholar
  57. 57. Cascorbi I. Role of pharmacogenetics of ATP-binding cassette transporters in the pharmacokinetics of drugs. Pharmacol. Ther. 2006; 112: 457-473.10.1016/j.pharmthera.2006.04.00916766035
    Search in Google Scholar
  58. 58. Tan E.K, Drozdzik M, Bialecka M. et al. Analysis of MDR1 haplotypes in Parkinson's disease in a white population. Neurosci. Lett. 2004; 372: 240-244.
    Search in Google Scholar
  59. 59. Gaikovitch EA, Cascorbi I, Mrozikiewicz PM et al. Polymorphisms of drug-metabolizing enzymes CYP2C9, CYP2C19, CYP2D6, CYP1A1, NAT2 and of P-glycoprotein in a Russian population. Eur. J. Clin. Pharmacol. 2003; 59: 303-312.
    Search in Google Scholar
  60. 60. Ameyaw MM, Regateiro F, Li T. et al. MDR1 pharmacogenetics: frequency of the C3435T mutation in exon 26 is significantly influenced by ethnicity. Pharmacogenetics 2001; 11: 217-221.10.1097/00008571-200104000-0000511337937
    Search in Google Scholar
  61. 61. Onnie CM, Fisher SA, Pattni R, Sanderson J, Forbes A, Lewis CM, Mathew CG. Associations of allelic variants of the multidrug resistance gene (ABCB1 or MDR1) and inflammatory bowel disease and their effects on disease behavior: a case-control and meta-analysis study. Inflamm Bowel Dis. 2006; 12(4): 263-71.10.1097/01.MIB.0000209791.98866.ba
    Search in Google Scholar
  62. 62. Ho GT, Nimmo ER, Tenesa A, et al. Allelic variations of the multidrug resistance gene determine susceptibility and disease behavior in ulcerative colitis. Gastroenterology. 2005; 128: 288-296.10.1053/j.gastro.2004.11.019
    Search in Google Scholar
  63. 63. Jeannessona E, Albertinia L, Siesta G, Gomesb AM, Ribeirob V, Aslanidisc C, et al. Determination of ABCB1 polymorphisms and haplotypes frequencies in a French population Fundamental and Clinical Pharmacology. 2007; 21: 411-41864. Bernal ML, Sinues B, Fanlo A and Mayayo E. Frequency distribution of C3435T mutation in exon 26 of the MDR1 gene in a Spanish population. Ther. Drug Monit. 2003; 25: 107-111.
    Search in Google Scholar
  64. 65. Vicente J, Sinues B, Fanlo A, Vasquez P, Medina JC, Martinez-Jarreta B. Polymorphism C3435T of the MDR1 gene in Central Americans and Spaniards. Mol Biol Rep. 2008; 35(3): 473-8.10.1007/s11033-007-9109-z
    Search in Google Scholar
  65. 66. Furuno T, Landi MT, Ceroni M, et al. Expression polymorphism of the blood-brain barrier component Pglycoprotein (MDR1) in relation to Parkinson's disease. Pharmacogenetics. 2002; 12: 529-534.10.1097/00008571-200210000-00004
    Search in Google Scholar
  66. 67. Palmieri O, Latiano A, Valvano R, D'Incà R, Vecchi M, Sturniolo GC, Saibeni S, et al. Multidrug resistance 1 gene polymorphisms are not associated with inflammatory bowel disease and response to therapy in Italian patients. Aliment Pharmacol Ther. 2005; 22(11-12): 1129-38.10.1111/j.1365-2036.2005.02701.x
    Search in Google Scholar
  67. 68. Petrova DT, Nedeva P, Maslyankov S, Toshev S, Yaramov N, Atanasova S, et al. No association between MDR1 (ABCB1) 2677G > T and 3435C > T polymorphism and sporadic colorectal cancer among Bulgarian patients. Cancer Res Clin Oncol. 2008; 134(3): 317-22.10.1007/s00432-007-0279-9
    Search in Google Scholar
  68. 69. Milojkovic M, Stojnev S, Jovanovic I, Ljubisavljevic S, Stefanovic V, Sunder-Plassman R. Frequency of the C1236T, G2677T/A and C3435T MDR1 gene polymorphisms in the Serbian population. Pharmacol Rep. 2011; 63(3): 808-14.10.1016/S1734-1140(11)70593-X
    Search in Google Scholar
  69. 70. Sabahi Z, Salek R, Heravi R, Mosaffa F, Avanaki Z and Behravan J. Association of gastric cancer incidence with MDR1 gene polymorphism in an ethnic Iranian population. Indian J Cancer. 2010; 47: 317-321.10.4103/0019-509X.6472320587910
    Search in Google Scholar
  70. 71. Hamdy S I, Hiratsuka M, Narahara K, Endo N, El- Enany M, Moursi N, et al. Genotype and allele frequencies of TPMT, NAT2, GST, SULT1A1 and MDR-1 in the Egyptian population. Br J Clin Pharmacol. 2003; 55: 560-569.10.1046/j.1365-2125.2003.01786.x188426812814450
    Search in Google Scholar
  71. 72. Sapmaz A, Ozen Karatayli SC, Dağli U, Kiliç ZM, Törüner M, Celik Y, et al. Effects of polymorphism in G2677T/A triallelic region of MDR1 gene in Turkish patients with inflammatory bowel disease. Turk J Gastroenterol. 2008; 19(3): 168-73.
    Search in Google Scholar
  72. 73. Omoto CK, Akamura TN, Akaeda TS, Roetz DLK, Amada TY, Matsu HO, et al. Regular article MDR1 haplotype frequencies in Japanese and Caucasian, and in Japanese patients with colorectal cancer and esophageal cancer. Drug Metab Pharmacokinet. 2006; 21: 126-132.10.2133/dmpk.21.12616702732
    Search in Google Scholar
  73. 74. Horinouchi M, Sakaeda T, Nakamura T, Morita Y, Tamura T, Aoyama N, et al. Significant genetic linkage of MDR1 polymorphisms at positions 3435 and 2677: functional relevance to pharmacokinetics of digoxin. Pharm Res. 2002; 19(10): 1581-5.10.1023/A:1020433422259
    Search in Google Scholar
  74. 75. Zheng H, Webber S, Zeevi A, Schuetz E, Zhang J, Lamba J, et al. The MDR1 polymorphisms at exons 21 and 26 predict steroid weaning in pediatric heart transplant patients. Human Immunol. 2002; 63: 765- 770.10.1016/S0198-8859(02)00426-3
    Search in Google Scholar
  75. 76. Li D, Zhang GL, Lou YQ, Li Q, Wang X, Bu XY. Genetic polymorphisms in MDR1 and CYP3A5 haplotype in mainland Chinese Han, Uygur and Kazakh ethnic groups. J Clin Pharm Ther. 2007; 32(1): 89-95.10.1111/j.1365-2710.2007.00791.x17286792
    Search in Google Scholar
  76. 77. Zhang WX, Chen GL, Zhang W, Tan ZR, Liu J, Zhou G, et al. MDR1 genotype do not influence tha absorption of a single oral dose of 100 mg talinolol in healthy Chinese males. Clin Chim Acta. 2005; 359(1- 2): 46-52.10.1016/j.cccn.2005.03.01016170863
    Search in Google Scholar
  77. 78. Kassogue Y, Dehbi H, Nassereddine S, Quachouh M and Nadifi S. Genotype Variability and Haplotype Frequency of MDR1 (ABCB1) Gene Polymorphism in Morocco. DNA and Cell biology. 2013; 32(10): 582-8.10.1089/dna.2013.210823930592
    Search in Google Scholar
  78. 79. http://www.ncbi.nih.gov/pojects/SNP/snp_ref.cgi?rs= 1128503
    Search in Google Scholar
  79. 80. Kimchi-Sarfaty C, Marple AH, Shinar S, Kimchi AM, Scavo D, Roma MI, et al. Ethnicity-related polymorphisms and haplotypes in human ABCB1 gene. Pharmacogenomics. 2007; 8(1): 29-39.10.2217/14622416.8.1.29187674817187507
    Search in Google Scholar
  80. 81. Estrela RC, Ribeiro FS, Carvalho RS, Gregório SP, Dias-Neto E, Struchiner CJ, Suarez-Kurtz G. Distribution of ABCB1 polymorphisms among Brazilians: impact of population admixture. Pharmacogenomics. 2008; 9(3): 267-76.10.2217/14622416.9.3.26718303963
    Search in Google Scholar
DOI: https://doi.org/10.1515/prilozi-2015-0016 | Journal eISSN: 1857-8985 | Journal ISSN: 1857-9345
Journal RSS Feed
Language: English
Page range: 121 - 133
Published on: Mar 1, 2015
Published by: Macedonian Academy of Sciences and Arts
In partnership with: Paradigm Publishing Services
Publication frequency: 2 times per year
Keywords:
ABCB1 (MDR1,
P-glycoprotein,
C1236T,
G2677A/T,
C3435T,
interethnic differences,
haplo-types Macedonian population
Related subjects:
Medicine,
Basic medical science,
History and ethics of medicine,
Clinical medicine,
Clinical medicine, other,
Social sciences,
Education,
Education, other

© 2015 Zorica Naumovska, Aleksandra K. Nestorovska, Zoran Sterjev, Ana Filipce, Aleksandar Dimovski, Ljubica Suturkova, published by Macedonian Academy of Sciences and Arts
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Previous articleVolume 35 (2014): Issue 3 (December 2014)Next article